...
首页> 外文期刊>Journal of experimental & clinical cancer research : >Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer
【24h】

Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer

机译:SIRT1和Notch1信号转导在乳腺癌中的相关性和预后价值

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background SIRT1 expression and Notch1 signaling have been implicated in tumorigenesis in many cancers, but their association with survival in breast cancer has not been determined. The purpose of this study was to assess the possible prognostic value of SIRT1, N1IC, and Snail expression in breast cancer patients. Methods Immunohistochemistry was performed to examine the expression of SIRT1, N1IC, and Snail, and the combined expression of SIRT1 and N1IC, using tissue microarrays containing breast cancer tissue and matched adjacent normal breast tissue from 150 breast cancer patients. Survival analysis was carried out using the Kaplan-Meier method. Univariate and multivariate analysis were used to evaluate the prognostic value of SIRT1, N1IC, Snail and combined SIRT1/N1IC expression, in addition to other clinicopathological factors, including grade, lymph node status, disease stage, and estrogen, progesterone, and human epidermal growth factor receptor 2 receptor status in breast carcinoma patients. Results SIRT1, N1IC, and Snail were all found to be highly expressed and an inverse correlation between SIRT1 and N1IC in breast cancer tissue. The three markers significantly correlated with lymph node status. Patients with low SIRT1 expression exhibited shorter overall survival (OS) and disease-free survival (DFS), and patients with combined low expression of SIRT1 and high expression of N1IC had the worse OS and DFS. Univariate and multivariate survival analysis revealed that low expression of SIRT1 and SIRT1-low/N1IC-high expression were independent prognostic factors for poor survival. Conclusions These results suggest that low expression of SIRT1 or the combined low expression of SIRT1 and high expression of N1IC could be used as indicators of poor prognosis, and may represent novel therapeutic targets in breast cancer.
机译:背景SIRT1表达和Notch1信号传导已牵涉到许多癌症的肿瘤发生中,但尚未确定它们与乳腺癌存活率的关系。这项研究的目的是评估SIRT1,N1IC和Snail表达在乳腺癌患者中的可能预后价值。方法采用免疫组织化学方法检测150例乳腺癌患者的乳腺癌组织及与之匹配的正常乳房组织的组织芯片,​​检测SIRT1,N1IC和Snail的表达,以及SIRT1和N1IC的联合表达。使用Kaplan-Meier方法进行生存分析。除其他临床病理因素,包括等级,淋巴结状态,疾病分期,雌激素,孕酮和人表皮生长之外,单因素和多因素分析还用于评估SIRT1,N1IC,Snail和SIRT1 / N1IC联合表达的预后价值。因子2受体在乳腺癌患者中的状态。结果发现SIRT1,N1IC和Snail均在乳腺癌组织中高表达,并且SIRT1和N1IC之间呈负相关。这三个标志物与淋巴结状态显着相关。 SIRT1表达低的患者表现出较短的总生存期(OS)和无病生存期(DFS),SIRT1低表达和N1IC高表达合并的患者的OS和DFS较差。单因素和多因素生存分析表明,SIRT1的低表达和SIRT1的低/ N1IC高表达是低生存率的独立预后因素。结论这些结果表明,SIRT1的低表达或SIRT1的低表达与N1IC的高表达相结合可作为预后不良的指标,并可代表乳腺癌的新治疗靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号